WST up +3.12% percent right now. $WST High is at 52.00 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 1:23 PM

WST up +3.12% percent right now. $WST High is at 52.00 and the Low 50.50 with current volume of 443,687.

Recent News posted below.

WST West Pharmaceutical Services Recent Headline News

West Receives 510(k) Clearance for NovaGuard(TM) SA Safety System
PR Newswire - Tue Nov 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
WST: 51.90 (+1.56)

Shares of WST Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 05, 9:43AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.37% as of today's recent price of $51.12.
WST: 51.90 (+1.56)

West Pharmaceuticals: A Little Giant In The Pharma Sector
Bill Gunderson - Seeking Alpha - Mon Nov 03, 9:26AM CST
West Pharmaceutical Services ( WST ) is an example of a good stock in a good sector. I like the health care sector in the current market environment but I prefer companies that are growing at a faster pace than the Eli Lillys ( LLY ) and Mercks ( ...
WST: 51.90 (+1.56), MRK: 59.49 (+0.68), LLY: 68.21 (-0.14)

West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.90 (+1.56)

West Pharmaceutical Services' (WST) CEO Don Morel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:27PM CDT

WST: 51.90 (+1.56)

West Pharmaceutical Services (WST) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:55AM CDT

WST: 51.90 (+1.56)

West Pharmaceutical beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:16AM CDT

WST: 51.90 (+1.56)

West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.90 (+1.56)

West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.90 (+1.56)

West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.90 (+1.56)

West Pharmaceuticals In Q3: The Cure For What Ails You?
Kurt Avard - at Seeking Alpha - Tue Oct 28, 12:38PM CDT

WST: 51.90 (+1.56)

The Week Ahead In Earnings Reports: Pharmaceuticals
Kurt Avard - at Seeking Alpha - Sat Oct 25, 4:32PM CDT

WST: 51.90 (+1.56), PFE: 30.26 (+0.06), MRK: 59.49 (+0.68)

West Pharma Services reports October 30
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:22PM CDT

WST: 51.90 (+1.56)

West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.90 (+1.56)

West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.90 (+1.56)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.90 (+1.56), GOOD: 18.08 (-0.09), GAIN: 7.31 (-0.04)

West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.90 (+1.56)

West Pharma chief to retire
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 8:45AM CDT

WST: 51.90 (+1.56)

West Pharmaceutical Services Announces CEO Retirement and Succession Plan
PR Newswire - Wed Oct 15, 7:22AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015. The West Board of Directors has retained Russell Reynolds Associates, a leading executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
WST: 51.90 (+1.56)

Global Pharmaceutical Packaging Market Outlook 2019: Key Players in the $86 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG
M2 - Mon Oct 13, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cbs5dv/global) has announced the addition of the "Global Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The pharmaceutical packaging market is expected to grow at a CAGR of 8.38% to reach $86.7 billion by the end of 2019 from the current estimates of $57.9 billion. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle, more and more people are being diagnosed with various diseases. With increased spending on healthcare by government of different countries world over, pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become a driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labelling of the products so that, it cannot be counterfeited and it should have a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Pharmaceutical Packaging Market by Primary Packaging Material 6. Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Pharmaceutical Packaging Market Segmentation by Region 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - Klockner Pentaplast - Meadwestvaco Corporation - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/cbs5dv/global
WST: 51.90 (+1.56)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...